Goldman now expects another 25-basis-point Fed increase in October after rates rose to 3.75%--4%.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

President Donald Trump‘s approval on inflation has fallen to 19%, a new low in the latest Marquette Law School poll. CNN chief data analyst Harry Enten called the resulting minus-61 net rating the worst presidential inflation reading on record. “This...
Commercial orbital laboratories could extend proven microgravity research, but regulation and return logistics remain unresolved.

It's important to understand the rule before you're ready to use it.
A $1 billion federal award doubles disclosed funding, but contracted wafer demand remains unknown.

Eli Lilly (LLY) grew revenue 48% in Q2 2026, driven by Zepbound and Mounjaro. A more understated metric for investors to watch is pricing. Lilly's U.S. price fell 9% from a year earlier, excluding changes to rebate estimates. So far, volume covers that cut. The risk is the quarter it cannot.

Recently, Jim Cramer interviewed OpenAI’s CFO Sarah Friar, noting that both OpenAI and Anthropic had backed calls to slow development on the most powerful AI models so safety protocols could catch up. When Cramer pressed her on whether OpenAI might slow its AI buildout, she explained the company would always make investment decisions by prioritizing […]

Earlier this month, Verizon expanded its 6G Innovation Forum by adding nine major partners, including AWS, Cisco, Intel, MediaTek, NVIDIA and others, and showcased ISAC-based crowd sensing, drone and vehicle tracking, and AI-powered fan experiences that use 5G Advanced and edge computing as a stepping stone toward future 6G capabilities. This broad, multi-partner push into 6G architectures and network-native sensing underscores how Verizon is working to position its network as a platform for...
A temporary exemption could unlock a much bigger shift
Three California depots expand freight infrastructure without revealing contract value, utilization or truck demand.

In recent days, Coinbase Global has faced renewed regulatory uncertainty after the Digital Asset Market Clarity Act failed to advance in the U.S. Senate, prompting CEO Brian Armstrong to urge the SEC and CFTC to set crypto rules under existing authority. At the same time, Coinbase is deepening its role in mainstream finance through partnerships such as X’s new Cashtag trading feature, even as Armstrong publicly campaigns to overhaul accredited investor rules to widen access to private-market...

Selective Insurance Group has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 15.8% to $88.57 per share while the index has gained 12.9%.
A confidential settlement restores project continuity but leaves GE's $360 million payment claim unresolved publicly.

Strive (ASST) heads into the H.C. Wainwright 28th Annual Global Investment Conference on September 15, 2026, with investors watching CFO and director Benjamin Bartley Pham for fresh clues on the asset manager’s direction. Strive’s recent trading tells a mixed story, with a 30-day share price return of 107.65% and a 90-day gain of 84.58% pointing to strong short-term momentum, while the 1-year total shareholder return has declined 62.76% and the 3-year total shareholder return is down...

Apple Inc (NASDAQ:AAPL, XETRA:APC) higher iPhone prices are largely offset by carrier incentives, according to Bank of America, which reiterated its "buy" rating. The bank cited capital returns, expected leadership in AI at the edge, and opportunities from new products and markets. BofA...

OpenAI’s finance chief answered Wall Street’s biggest AI worry on live TV this week.
Cross-network identity may accelerate autonomous payments while weakening control over the verification layer.

ChargePoint stock surged 61% in a single month while every sector peer moved the opposite direction, and nobody can point to a catalyst that explains it. That combination of facts makes the buy-or-wait decision unusually uncomfortable right now.

SpaceX on Thursday announced they have postponed their upcoming Starship test flight 14 launch. CEO Elon Musk and the company did not immediately share a reason for the delay. SpaceX on Thursday said it is now targeting to launch Starship flight 14 as early as Monday, Sept. 28, pending regulatory approval.
Thales is pitching export-control independence against Maven, turning data sovereignty into a procurement variable.
RBC's 2027 forecasts sit above consensus on organic revenue and earnings

Intuitive Surgical (ISRG), maker of the da Vinci surgical robots, trades at about $382, some 36% below its 52-week high. Even so, you pay about 35.9 times trailing adjusted earnings. That is normalized net income with stock-based compensation added back, a basis meant to sit closer to the one analysts forecast on, though the two are not defined identically. Analysts' forecasts run to 2027, the year Intuitive plans to start lowering what customers pay per use on some instruments.

Over the last six months, International Paper’s shares have sunk to $34.16, producing a disappointing 8.7% loss - a stark contrast to the S&P 500’s 12.9% gain. This may have investors wondering how to approach the situation.
Barra expects $700 million of defense revenue this year at double-digit margins
DoorDash and Uber are giving Costco a much wider digital reach at an important moment for its membership business.

MARA Holdings (NASDAQ:MARA) stock is rallying in Thursday afternoon trading, with MARA shares up 6% to $11.76. Over the past month, MARA has gained 21%, a run that puts the stock well ahead of both its listed peers and the broad market benchmark. For context, the SPDR S&P 500 ETF Trust (NYSEARCA:SPY) has declined 1% […]

Wall Street seems to be neutral on the subject as shares of Nike are trading up just over 1 percent on Thursday.

Johnson & Johnson (NYSE:JNJ) Executive Vice President and Chief Financial Officer Joe Wolk said the company sees a path to growth above its previously stated 5% to 7% long-term range, supported by its pharmaceutical pipeline, medical technology portfolio and capital flexibility. Speaking at a Deuts

Fieldly's $494,000 purchase brings his direct holdings to 956,063 shares worth $25.5 million, signaling confidence amid recent weakness.
